ConductScience.org, home

Paper21685232

Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.

Munger KL and 4 others. Mult Scler, 2011. Cited by 166 papers, by iCite.

Cite this record

ConductScience Library. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Papers, record 21685232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21685232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
PubMed
Journal
Mult Scler
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
166
iCite
Relative citation ratio, by iCite
4.84
iCite
Revised in PubMed
2025-05-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Munger KLK L
2Levin LIL I
3O'Reilly EJE J
4Falk KIK I
5Ascherio AA

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
BiomarkersMajor topic
Epstein-Barr Virus InfectionsMajor topic
Multiple SclerosisMajor topic
Adolescent
Adult
Area Under Curve
Case-Control Studies
Epstein-Barr Virus Nuclear Antigens
Female
Humans
Male
Military Personnel
Prospective Studies
ROC Curve
Radioimmunoassay
Risk Factors
United States
Vitamin D
Young Adult

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 NS042194NINDS NIH HHSUnited StatesR01NS042194PubMed and NIHNIH RePORTER
R01 NS046635NINDS NIH HHSUnited StatesR01NS046635PubMed and NIHNIH RePORTER
NS042194NINDS NIH HHSUnited StatesR01NS042194PubMed and NIHNIH RePORTER
NS046635NINDS NIH HHSUnited StatesR01NS046635PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07924410Tele-rehabilitation Program in People With Multiple Sclerosis and Mild DisabilityBackground

Source ClinicalTrials.gov

Download CSV of trials

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115841210Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.J Clin Invest2005https://conductscience.org/library/papers/15841210PubMed
217984305Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.J Exp Med2007https://conductscience.org/library/papers/17984305PubMed
319638446Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.Brain2009https://conductscience.org/library/papers/19638446PubMed
411021623Epstein-Barr virus and multiple sclerosis.Epidemiology2000https://conductscience.org/library/papers/11021623PubMed
512453804The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance.Am J Public Health2002https://conductscience.org/library/papers/12453804PubMed
620824132An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.PLoS One2010https://conductscience.org/library/papers/20824132PubMed
714982728Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells.J Neurovirol2004https://conductscience.org/library/papers/14982728PubMed
819917644Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.Brain2010https://conductscience.org/library/papers/19917644PubMed
917179460Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.JAMA2006https://conductscience.org/library/papers/17179460PubMed
1012653848Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.Clin Exp Immunol2003https://conductscience.org/library/papers/12653848PubMed
1116569670Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.Brain2006https://conductscience.org/library/papers/16569670PubMed
1217329717HLA-DR15 haplotype and multiple sclerosis: a HuGE review.Am J Epidemiol2007https://conductscience.org/library/papers/17329717PubMed
1320237306EBV and brain matter(s)?Neurology2010https://conductscience.org/library/papers/20237306PubMed
1415100207Epstein-Barr virus in pediatric multiple sclerosis.JAMA2004https://conductscience.org/library/papers/15100207PubMed
1516502434Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis.Ann Neurol2006https://conductscience.org/library/papers/16502434PubMed
1615210894An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.Neurology2004https://conductscience.org/library/papers/15210894PubMed
1719525955Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.Nat Genet2009https://conductscience.org/library/papers/19525955PubMed
1830076061 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production.J Immunol1986https://conductscience.org/library/papers/3007606PubMed
1920220124Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.Neurology2010https://conductscience.org/library/papers/20220124PubMed
2017492755Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors.Ann Neurol2007https://conductscience.org/library/papers/17492755PubMed

See all 34 referencesDownload CSV of references

Cited by90

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.

PMIDTitleJournalYearIn PapersSource
42956321Epstein-Barr Virus Serologic Profiles in Multiple Sclerosis and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.Neurol Neuroimmunol Neuroinflamm2027https://conductscience.org/library/papers/42956321PubMed
42898310High EBV-reactive IgG levels in serum are linked to typical inflammatory cerebrospinal fluid features in multiple sclerosis.Front Immunol2026https://conductscience.org/library/papers/42898310PubMed
42743450EBNA1381-452 and Cross-Reactive Antibody Responses Reveal Immune Signatures in Multiple Sclerosis.Neurol Neuroimmunol Neuroinflamm2026https://conductscience.org/library/papers/42743450PubMed
42654984Epstein-Barr Virus and Multiple Sclerosis: Mechanistic Insights into Virus-Driven Autoimmunity.Microorganisms2026https://conductscience.org/library/papers/42654984PubMed
42112902Epstein-Barr virus receptors: classification, functional mechanisms, and pathogenic implications.J Virol2026https://conductscience.org/library/papers/42112902PubMed
41919465Why Is MS a More Frequent Complication of EBV Infection in Females?Immunol Rev2026https://conductscience.org/library/papers/41919465PubMed
41707657Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.Cell Rep Med2026https://conductscience.org/library/papers/41707657PubMed
41235241Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair.Front Immunol2025https://conductscience.org/library/papers/41235241PubMed
41098679Emerging Insights into the Role of Macrophages in Multiple Sclerosis: Pathogenesis and Potential Therapeutic Strategies.J Inflamm Res2025https://conductscience.org/library/papers/41098679PubMed
40970118Intrathecally expanded GZMK+/GZMH+ CD8 T cells targeting EBV antigens may reduce severity of Multiple Sclerosis.medRxiv2025https://conductscience.org/library/papers/40970118PubMed
40953326Epstein-Barr Virus in Multiple Sclerosis: Past, Present, and Future.Neurol Neuroimmunol Neuroinflamm2025https://conductscience.org/library/papers/40953326PubMed
40636815Multiple sclerosis: 2024 update.Free Neuropathol2025https://conductscience.org/library/papers/40636815PubMed
39962592Knowledge mapping of childhood infectious mononucleosis: a bibliometric analysis for the twenty-first century.J Health Popul Nutr2025https://conductscience.org/library/papers/39962592PubMed
39776919EBV-specific T-cell immunity: relevance for multiple sclerosis.Front Immunol2024https://conductscience.org/library/papers/39776919PubMed
39524581Epstein-Barr virus flare: A multiple sclerosis attack.Surg Neurol Int2024https://conductscience.org/library/papers/39524581PubMed
39505801Research landmarks on the 60th anniversary of Epstein-Barr virus.Sci China Life Sci2025https://conductscience.org/library/papers/39505801PubMed
38843296Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.PLoS Pathog2024https://conductscience.org/library/papers/38843296PubMed
38361801Insights into the interplay between Epstein-Barr virus (EBV) and multiple sclerosis (MS): A state-of-the-art review and implications for vaccine development.Health Sci Rep2024https://conductscience.org/library/papers/38361801PubMed
38338973A Blood Test for the Diagnosis of Multiple Sclerosis.Int J Mol Sci2024https://conductscience.org/library/papers/38338973PubMed
38338799Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms.Int J Mol Sci2024https://conductscience.org/library/papers/38338799PubMed

See all 90 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-DRB13123PubTator's text mininghttps://conductscience.org/library/genes/3123NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21685232

GET https://conductscience.org/api/papers/v1/21685232/references?page=2